Skip to main content
OpenTrials
Completed

NCT Number: NCT00527098

Optimal Fluid Resuscitation for Trauma Patients

The purpose of this study is to determine if the overall fluid requirements for the first 24 hours after admission will be reduced with Hextend versus a standard of care crystalloid resuscitation fluid.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Trauma Wounds and Injuries

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ryder Trauma Center

Miami, Florida, 33136, United States

About this study

Following severe multi-system traumatic injury, the first 24 hours of standard resuscitation fluid will be either Hextend or crystalloid depending upon attending preference. No tests or interventions will be performed for research purposes.

Data will be collected prospectively from patient medical records and attending clinicians to monitor fluid requirements, hemodynamics and outcome.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Greater than or equal to 18 years old and less than 65 years old
  • Admission with multi-system traumatic injury
  • Admission to the intensive care unit

Exclusion criteria

  • Less than 18 or greater than 65 years old
  • Pregnant or lactating
  • No fluid resuscitation

Treatment and study plan

Primary outcomes

  1. Mortality

    Time frame: From hospital arrival up to an average of 3.5 weeks

Sponsors and collaborators

Lead sponsor

University of Miami

Other

Registry information

Important dates

Study start
2007
Primary completion
2010
Study completion
2010
First posted
Sep 10, 2007
Registry last updated
Feb 22, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.